SMAD4 and melanoma: ALK5 inhibition induced ubiquitin-mediated degradation of Smad4 in CD8+ T cells in addition to the direct inhibition of R-Smad phosphorylation to enhance anti-melanoma CTL responses through derepressing Eomes.